GLP-1 Medications and Muscle Loss: How to Train and Eat While on Ozempic or Mounjaro

Most people who start a GLP-1 medication lose weight. That's the point, and the drugs deliver on it spectacularly. Semaglutide produces average weight loss of 15%, tirzepatide up to 21% (Wilding et al., 2021; Jastreboff et al., 2022). These are numbers that were unthinkable five years ago without surgery.

But here's the part your prescribing doctor probably didn't mention: up to 40% of that weight you're losing isn't fat. It's lean mass. Muscle, organ tissue, the metabolically active stuff that keeps you strong, mobile, and healthy (Dubin et al., 2024). One research group calculated that the muscle loss seen over a single 68-week treatment course is roughly equivalent to a decade or more of normal age-related decline (Locatelli et al., 2024).

Lose 20 kilos and celebrate. Then realise that 5 to 8 of those kilos might have been the tissue keeping your metabolism running, your joints stable, and your body capable of doing things at 60 that you could do at 40.

The drugs are groundbreaking. Nobody serious disputes that. But a groundbreaking tool used without the right protocol is just an expensive way to create a new set of problems.

What the Drugs Actually Do to Your Body

GLP-1 receptor agonists work primarily by suppressing appetite. They slow gastric emptying, signal satiety to the brain, and make you genuinely less interested in food. The result is a dramatic reduction in caloric intake: studies show GLP-1 users eat up to 40% less than they did before starting treatment (Kerlikowsky et al., 2025).

That's a double-edged mechanism. Eat 40% less and you will lose weight. But eat 40% less without adjusting what you eat and how you train, and your body doesn't discriminate. It takes the energy deficit from wherever it can, and muscle is an expensive tissue to maintain. When calories drop sharply, your body starts stripping it.

The SURMOUNT-1 DXA sub-study put numbers on this: participants on tirzepatide lost 21.3% of their body weight, of which approximately 75% was fat mass and 25% was lean mass (Look et al., 2025). That 25% figure is the optimistic end. A comprehensive review of 28 clinical trials found the lean mass percentage ranged from 20% to 40%, with the majority exceeding 25% (Dubin et al., 2024).

Then there are the side effects. Pooled data from the STEP trials (over 3,300 participants) shows nausea in 44% of users, diarrhoea in 30%, vomiting in 25%, and constipation in 24% (Wharton et al., 2022). The vast majority are mild to moderate and concentrated during dose escalation. But when you're nauseous and eating a fraction of your normal intake, making good food choices becomes harder. Real-world patient data reports fatigue in nearly 10% of users (Bhagavathula, 2025). Low energy, low appetite, and a body that's shedding muscle. Without intervention, the trajectory is not a good one.

The Hidden Risk: Losing Weight but Getting Weaker

There's a term in clinical nutrition called sarcopenic obesity: low muscle mass combined with high or redistributed body fat. It's traditionally associated with ageing and inactivity. The concern with GLP-1 medications is that rapid weight loss without resistance training can accelerate exactly this pattern in people who are decades younger than the typical sarcopenic patient.

CT imaging of 241 patients on semaglutide showed significant decreases in both visceral fat and muscle area, alongside decreased muscle quality in those who regained weight (Nelson et al., 2024). You lose the fat, which is good. But you also lose the muscle, and if you stop the medication without having built or maintained that muscle, you're in a worse metabolic position than when you started.

Bone density follows a similar pattern. A review of the evidence found that significant weight reduction through calorie restriction, including GLP-1-mediated restriction, results in high-turnover bone loss, with early data suggesting slight reductions in bone mineral density (Karam et al., 2025). Rapid weight loss is a mechanical unloading event for your skeleton. Less weight pressing down means less stimulus for bone to maintain itself.

None of this means the drugs are bad. It means the drugs alone aren't enough.

The Training Protocol: Resistance Training Is Non-Negotiable

If you're on a GLP-1 medication and you're not doing structured resistance training, you're accepting unnecessary muscle loss. The evidence on this is clear.

A review in Diabetes Care found that supervised resistance training programmes lasting more than 10 weeks can produce approximately 3 kg of lean mass gain and around 25% increases in strength, even during active weight loss (Locatelli et al., 2024). That's not just slowing the losses. That's reversing the direction for muscle while the fat continues to come off.

The strongest evidence comes from a landmark New England Journal of Medicine trial combining exercise with liraglutide (an older GLP-1). The combination group achieved 9.5 kg of additional weight loss beyond the initial diet phase, but critically, only the combination decreased body fat percentage by 3.9 percentage points, roughly double the reduction of either exercise or medication alone (Lundgren et al., 2021). Only the combination improved insulin sensitivity, cardiorespiratory fitness and glycated haemoglobin simultaneously.

The medication handles the caloric deficit. The training tells your body what to keep.

In practice, this means:

• Three to four resistance sessions per week. Full-body or upper/lower splits. Compound movements: squats, deadlifts, presses, rows, lunges.
• Progressive overload. The weights need to go up over time. This is the signal that tells your body muscle is essential and shouldn't be broken down for energy.
• Adequate intensity. Training to within 2-3 reps of failure on working sets. Light weights for high reps won't provide enough stimulus when you're in a significant caloric deficit.
• Don't skip sessions because you're nauseous. Adjust the session: lower the volume, keep the intensity. A shorter, harder session preserves more muscle than skipping entirely.

The Nutrition Protocol: Protein First, Everything Else Second

When you're eating 40% less food, every meal has to count. The margin for error disappears. A consensus statement from the International Symposium on Diabetes and Nutrition recommends protein intakes above 1.2 g/kg/day, evenly distributed across meals, for anyone on GLP-1 therapy (Noronha et al., 2025). Other reviews push that ceiling higher, recommending 1.2 to 2.0 g/kg/day when combined with resistance training (Mechanick et al., 2024; Johnson et al., 2025).

For an 80 kg person, that's 96 to 160 grams of protein daily. When your appetite is suppressed and your total food intake is down, hitting that target requires deliberate planning.

The practical approach:

• Protein at every meal. Eggs, chicken, fish, Greek yoghurt, lean red meat. If you're only eating two meals a day because your appetite has vanished, both meals need to be protein-dominant.
• Whole, nutrient-dense foods over processed options. When total volume is low, you can't afford empty calories. Every meal needs to deliver protein, vitamins, and minerals simultaneously.
• Consider a protein supplement. Not as a replacement for food, but as insurance. A whey protein shake can bridge the gap on days when nausea makes solid food difficult. Research supports whey protein specifically for lean mass preservation during weight loss (Johnson et al., 2025).
• Distribute protein across the day. Three to four servings of 30-40 grams is more effective for muscle protein synthesis than one large bolus.

Plug the Micronutrient Gaps

This is the part almost nobody talks about. If you're eating 40% less food, you're getting 40% fewer vitamins and minerals. GLP-1 users are a population already characterised by high baseline nutritional inadequacy (Koceva et al., 2026). Layer a dramatic reduction in food intake on top of that and the gaps widen quickly.

A quality multivitamin is a reasonable baseline. Beyond that, specific supplements with evidence in this context include:

• Creatine monohydrate (3-5g daily): supports muscle retention and strength, well-established safety profile (Sanchis-Gomar et al., 2025)
• Vitamin D: important for bone density during a period of rapid weight loss and mechanical unloading
• Omega-3 fatty acids: anti-inflammatory, supports muscle protein synthesis
• Fibre and probiotics: can help mitigate the GI side effects that affect nearly half of users (Johnson et al., 2025)

These aren't performance supplements. They're gap fillers for a situation where your food intake can no longer cover basic requirements.

The Combination Is the Protocol

The most important finding across all of this research is that the combination of GLP-1 medication, structured resistance training, and adequate protein intake produces results that none of these elements achieve alone. The Lundgren trial in the New England Journal of Medicine showed this definitively: exercise plus medication produced double the body fat reduction and was the only approach that simultaneously improved fitness, insulin sensitivity, and body composition (Lundgren et al., 2021).

The medication creates the deficit. The training preserves the muscle. The nutrition fuels the recovery. Remove any one of those three and you're leaving results on the table, or worse, creating problems that will surface months or years down the line.

GLP-1 medications are, without exaggeration, the most significant development in obesity treatment in decades. They work. But they're a tool, and like any tool, the outcome depends entirely on how you use it. A hammer builds a house or puts a hole in a wall. The hammer doesn't care which.

Get the training right. Get the nutrition right. Let the medication do what it does best. That's how you lose fat, keep muscle, and come out the other side genuinely healthier, not just lighter.

Frequently Asked Questions

How much muscle do you lose on Ozempic or Mounjaro?

Research shows that 20-40% of total weight lost on GLP-1 medications is lean mass rather than fat (Dubin et al., 2024). In a 20 kg weight loss, that could mean 4-8 kg of muscle and other lean tissue. Resistance training and adequate protein intake can significantly reduce this.

What should I eat while on semaglutide?

Prioritise protein at every meal, aiming for 1.2-2.0 g/kg of body weight daily (Mechanick et al., 2024). Focus on whole, nutrient-dense foods: lean meats, fish, eggs, vegetables, and whole grains. Since GLP-1s can reduce food intake by up to 40%, every meal needs to deliver maximum nutritional value.

Can I build muscle while taking GLP-1 medications?

Yes. Supervised resistance training programmes lasting more than 10 weeks have shown approximately 3 kg of lean mass gain and 25% strength increases, even during active weight loss on GLP-1 therapy (Locatelli et al., 2024). The key is structured progressive overload with adequate protein intake.

Should I take supplements while on Ozempic?

A quality multivitamin, creatine monohydrate (3-5g daily), vitamin D, and omega-3 fatty acids are worth considering. When food intake drops significantly, micronutrient gaps become likely (Kerlikowsky et al., 2025). Fibre and probiotics can also help manage the GI side effects that affect up to 44% of users.

How often should I train while on GLP-1 medications?

Three to four resistance training sessions per week, focusing on compound movements with progressive overload. The combination of exercise and GLP-1 medication produces double the body fat reduction of either alone (Lundgren et al., 2021).

On a GLP-1 and want to make sure you're training and eating correctly? At RWC, our coaches design strength programmes specifically for clients on these medications, with the nutrition guidance to match. Get in touch and we'll build a protocol that protects your muscle while the medication does its job.